News & Events Upcoming events Oct 21, 2026 - Oct 23, 2026 MSToronto 2026 - 10th Joint ACTRIMS-ECTRIMS Meeting Toronto, Canada More info and meet us there Nov 16, 2026 - Nov 19, 2026 MEDICA 2026 Düsseldorf, Germany More info and meet us there Nov 16, 2026 - Nov 19, 2026 19th Clinical Trials on Alzheimer's Disease (CTAD) Boston, MA, United States of America More info and meet us there See all upcoming events Latest news Feb 11, 2007 Fujirebio Diagnostics and ARUP Laboratories Sign Exclusive Agreement for MESOMARK® Testing Read more Feb 6, 2007 NYU Study Validates Use of the Fujirebio Diagnostics MESOMARK® Test for Monitoring an Asbestos-linked Cancer Read more Jan 24, 2007 Fujirebio Diagnostics Receives FDA Approval for the MESOMARK® Assay for the Management of Mesothelioma Patients Read more May 30, 2006 Fujirebio Diagnostics Acquires CanAg Diagnostics Read more Dec 18, 2005 Fujirebio Diagnostics Named One of Best Places to Work in PA Read more Nov 6, 2005 Fujirebio Diagnostics Honored with Pioneer Award from MARF Read more Load More
Oct 21, 2026 - Oct 23, 2026 MSToronto 2026 - 10th Joint ACTRIMS-ECTRIMS Meeting Toronto, Canada More info and meet us there
Nov 16, 2026 - Nov 19, 2026 19th Clinical Trials on Alzheimer's Disease (CTAD) Boston, MA, United States of America More info and meet us there
Feb 11, 2007 Fujirebio Diagnostics and ARUP Laboratories Sign Exclusive Agreement for MESOMARK® Testing Read more
Feb 6, 2007 NYU Study Validates Use of the Fujirebio Diagnostics MESOMARK® Test for Monitoring an Asbestos-linked Cancer Read more
Jan 24, 2007 Fujirebio Diagnostics Receives FDA Approval for the MESOMARK® Assay for the Management of Mesothelioma Patients Read more
